XML 61 R43.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Equity (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Banking Regulation, Total Capital [Abstract] |
Schedule of breakdown of the company’s share capital |
|  | December 31, 2021 |  | December 31, 2020
|  | Issued and outstanding |  | Authorized |  | Issued and outstanding |  | Authorized
|  | Number of shares
Ordinary Shares, NIS 0.01 par value |  | 16,617,397 |  | 110,714,286 |  | 54,396,834 |  | 690,000,000
Ordinary “A” Shares, NIS 0.01 par value |  | — |  | — |  | — |  | 10,000,000
|  | 16,617,397 |  | 110,714,286 |  | 54,396,834 |  | 700,000,000
Schedule of share-based payment balance |
|  | Year Ended December 31, 2021
|  | Number of options |  | Weighted Average- Exercise Price |  | Weighted Average remaining contractual term in years
Share options outstanding at beginning of year |  | 5,544,611 |  |  | $ | 0.678 |  | 3.82
1:28 reverse options split(*) |  | (5,346,589 | ) |  |  | — |  | —
Share options granted during the year |  | 6,768,045 |  |  | $ | 0.2304 |  | 9.72
Share options exercised during the year |  | (59,510 | ) |  | $ | 0.09 |  | —
Share options forfeited/expired during the year |  | (142,342 | ) |  | $ | 0.6783 |  | —
Share options outstanding at end of year |  | 6,764,215 |  |  | $ | 0.2972 |  | 9.73
Share options exercisable at end of year |  | 2,861,715 |  |  | $ | 0.2849 |  | 9.71
|  | Year Ended December 31, 2020
|  | Number of options |  | Weighted Average- Exercise Price |  | Weighted Average remaining contractual term in years
Share options outstanding at beginning of year |  | 5,860,030 |  |  | $ | 0.677 |  | 4.59
Share options forfeited/expired during the year |  | (315,419 | ) |  | $ | 0.334 |  | —
Share options outstanding at end of year |  | 5,544,611 |  |  | $ | 0.678 |  | 3.82
Share options exercisable at end of year |  | 4,269,167 |  |  | $ | 0.504 |  | 4.5
Schedule of company capital instruments |
|  | Year ended December 31, 2021
Dividend yield (%) |  | 0%
Expected volatility in share prices (%) |  | 56.08% – 77.3%
Risk-free interest rate (%) |  | 0.10% – 1.401%
Predicted life of share (in years) |  | 2.25 – 10
Share price (NIS) |  | 5.295 – 7.07
Schedule of consolidated financial statements |
|  | Year Ended December 31, 2021
|  | 2021 |  | 2020
|  | U.S. dollars in thousands
Cost of revenues |  | 603 |  | 4
Research and development expenses |  | 1,607 |  | 89
Sales and marketing expenses |  | 1,770 |  | 12
General and administrative expenses |  | 3,205 |  | 582
Total expenses – share-based payments plan |  | 7,185 |  | 687

X
- References No definition available. + Details
Name: | onds_ScheduleOfBreakdownOfTheCompanysShareCapitalTableTextBlock
Namespace Prefix: | onds_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | onds_ScheduleOfCompanyCapitalInstrumentsTableTextBlock
Namespace Prefix: | onds_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | onds_ScheduleOfConsolidatedFinancialStatementsTableTextBlock
Namespace Prefix: | onds_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | onds_ScheduleOfSharebasedPaymentBalanceTableTextBlock
Namespace Prefix: | onds_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_CapitalAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration